These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 10839755
1. The potential for vaccine development against chlamydial infection and disease. Brunham RC, Zhang DJ, Yang X, McClarty GM. J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755 [Abstract] [Full Text] [Related]
3. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Barker CJ, Beagley KW, Hafner LM, Timms P. Vaccine; 2008 Mar 04; 26(10):1285-96. PubMed ID: 18261829 [Abstract] [Full Text] [Related]
5. Contemporary approaches to designing and evaluating vaccines against Chlamydia. Igietseme JU, Eko FO, Black CM. Expert Rev Vaccines; 2003 Feb 04; 2(1):129-46. PubMed ID: 12901604 [Abstract] [Full Text] [Related]
12. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO. J Microbiol Immunol Infect; 2007 Jun 04; 40(3):188-200. PubMed ID: 17639158 [Abstract] [Full Text] [Related]
17. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Finco O, Bonci A, Agnusdei M, Scarselli M, Petracca R, Norais N, Ferrari G, Garaguso I, Donati M, Sambri V, Cevenini R, Ratti G, Grandi G. Vaccine; 2005 Jan 19; 23(9):1178-88. PubMed ID: 15629361 [Abstract] [Full Text] [Related]
20. DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. Penttilä T, Tammiruusu A, Liljeström P, Sarvas M, Mäkelä PH, Vuola JM, Puolakkainen M. Vaccine; 2004 Sep 03; 22(25-26):3386-94. PubMed ID: 15308363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]